Carbamazepine and oxcarbazepine in adult patients with Dravet syndrome: Friend or foe?

Akiyama, 2010, A long-term follow-up study of Dravet syndrome up to adulthood, Epilepsia, 51, 1043, 10.1111/j.1528-1167.2009.02466.x Auvin, 2013, Stiripentol exhibits higher anticonvulsant properties in the immature than in the mature rat brain, Epilepsia, 54, 2082, 10.1111/epi.12401 Brunklaus, 2012, Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome, Brain, 135, 2329, 10.1093/brain/aws151 Catarino, 2011, Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology, Brain, 134, 2982, 10.1093/brain/awr129 Catterall, 2014, Sodium channels, inherited epilepsy, and antiepileptic drugs, Annu Rev Pharmacol Toxicol, 54, 317, 10.1146/annurev-pharmtox-011112-140232 Depienne, 2009, Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients, J Med Genet, 46, 183, 10.1136/jmg.2008.062323 Dravet, 2005, Severe myoclonic epilepsy in infancy (Dravet syndrome), 89 Dravet, 2011, Dravet syndrome, vol. 3, 67 Genton, 2011, Dravet syndrome: the long-term outcome, Epilepsia, 52, 44, 10.1111/j.1528-1167.2011.03001.x Guerrini, 1998, Lamotrigine and seizure aggravation in severe myoclonic epilepsy, Epilepsia, 39, 508, 10.1111/j.1528-1157.1998.tb01413.x Horn, 1986, Carbamazepine-exacerbated epilepsy in children and adolescents, Pediatr Neurol, 2, 340, 10.1016/0887-8994(86)90074-3 Oakley, 2013, Synergistic GABA-enhancing therapy against seizures in a mouse model of Dravet syndrome, J Pharmacol Exp Ther, 345, 215, 10.1124/jpet.113.203331 Oguni, 2001, Severe myoclonic epilepsy in infants – a review based on the Tokyo Women's Medical University series of 84 cases, Brain Dev, 23, 736, 10.1016/S0387-7604(01)00276-5 Rilstone, 2012, Dravet syndrome: seizure control and gait in adults with different SCN1A mutations, Epilepsia, 53, 1421, 10.1111/j.1528-1167.2012.03583.x Wakai, 1996, Severe myoclonic epilepsy in infancy and carbamazepine, Eur J Pediatr, 155, 724, 10.1007/BF01957165 Wang, 1996, Severe myoclonic epilepsy in infancy: evolution of electroencephalographic and clinical features, Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, 37, 428 Xu, 2014, Early clinical features and diagnosis of Dravet syndrome in 138 Chinese patients with SCN1A mutations, Brain Dev, 36, 676, 10.1016/j.braindev.2013.10.004 Yu, 2006, Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy, Nat Neurosci, 9, 1142, 10.1038/nn1754